Laboratory Test Detail

Last Updated: August 11, 2020 @ 9:13 am

1131

Chlamydia Aptima

Specimen:Collect:
  • Genital Swab in Aptima Kit-Multitest (Orange)

Also Acceptable:
  • Other in Aptima Kit-Multitest (Orange)
  • Rectal Swab in Other in Aptima Kit-Multitest (Orange)
  • Throat Swab in Rectal Swab in Other in Aptima Kit-Multitest (Orange)
  • Vaginal Secretions in Throat Swab in Rectal Swab in Other in Aptima Kit-Multitest (Orange)
  • Endocervical Swab in Aptima Kit-Unisex (White)
  • Urethral Swab in Endocervical Swab in Aptima Kit-Unisex (White)
  • Random Urine in Aptima Kit-Urine (Yellow)
  • Random Urine in Sterile Specimen Container
Submit:
  • Genital Swab in Aptima Kit-Multitest (Orange). Submit Refrigerated.

Also Acceptable:
  • Random Urine in Aptima Kit-Urine (Yellow). Submit Refrigerated.
  • Random Urine in Sterile Specimen Container. Submit Refrigerated.
  • Throat Swab . Submit .
  • Rectal Swab . Submit .
  • Endocervical Swab . Submit .
  • Urethral Swab . Submit .
  • Vaginal Secretions . Submit .
  • Other . Submit .
Special Handling:
  • Urethral Swab: Male only
    Urine Specimens: The patient should not have urinated for at least one hour prior to sampling. Do not cleanse the area prior to providing the specimen. Direct the patient to provide first-catch urine into a urine collection cup and then transfer appropriate amount of specimen into the transport tube. Liquid must fall between 2 black indicator lines on APTIMA Kit. Please note: Sterile urine stable for 24-hours before being transferred to APTIMA kit.

    Testing can be performed on liquid pap media. Please call Interpath Pathology for further details (206) 623-3814.
Stability:Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: 12 Month(s); Incubated: Unacceptable
Methodology:
  • Target Amplified Nucleic Acid Probe
Performed:Mon-Fri
Reported:1-3 Day(s)
CPT Codes:
  • 87491
Interpretive Data:Please see report for interpretive data.

The Aptima Combo 2 Assay is a qualitative nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC). The analytic performance characteristics have been determined by Interpath Laboratory for sources not FDA approved. Results depend on sufficient levels of DNA to be detected, absence of inhibitors and adequate sample collection. Results should be interpreted in conjunction with clinical findings and should not preclude additional studies if findings do not correlate.
Components:
  • 1127 - CHLAMYDIA
  • 1128 - SOURCE
Print Friendly, PDF & Email

Disclaimer:
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.